Inhibitors of prolyl oligopeptidases for the therapy of human diseases: defining diseases and inhibitors.
Lawandi
Janice
J
Department of Chemistry, McGill University, 801 Sherbrooke Street West, Montreal, Quebec H3A 2K6, Canada.
Gerber-Lemaire
Sandrine
S
Juillerat-Jeanneret
Lucienne
L
Moitessier
Nicolas
N
D000818:Animals; D001812:Blood-Brain Barrier; D002490:Central Nervous System; D006801:Humans; D000085822:Prolyl Oligopeptidases; D011485:Protein Binding; D012697:Serine Endopeptidases / Q000187:drug effects / Q000378:metabolism*; D015842:Serine Proteinase Inhibitors / Q000627:therapeutic use*
D015842:Serine Proteinase Inhibitors; D012697:Serine Endopeptidases; C000705287:PREPL protein, human; D000085822:Prolyl Oligopeptidases